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potassium have also been shown in patients with MSK,
potentially contributing to the pathogenesis of nephrolithiasis.3
This renal malformation is frequently associated with
nephrocalcinosis and renal stones. In particular, MSK is
associated with a 60% lifetime risk of renal stones, and the
prevalence of MSK in patients with renal stones is
significantly higher (8.5%, Po0.01) than in the control
population (1.5%).4
As MSK was diagnosed only after the introduction of
intravenous urography in the 1930s (Figure 1), and
conventional computed tomography, which has been pre-
ferred since the mid-1990s, is not satisfactory for unmasking
MSK, except when using multidetector-row computed
tomography of high-resolution three-dimensional displays
and late urographic images, ‘there is a concrete possibility of
this renal condition being forgotten in the future.’2 Therefore,
it seems to be even more mandatory not to miss MSK in
reviews of renal stones.
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I agree with Stratta et al.1 that the association of various
malformative disorders with medullary sponge kidney
(MSK) is interesting, yet challenging. These various asso-
ciations have led to the hypothesis that embryological
nephronal maldevelopment may participate in the patho-
genesis of this disease.2 However, as stated in a very recent
article published in this journal, the pathogenesis of MSK
has not yet been fully elucidated.2 Although multiple
candidate genes have been proposed to play a role in the
process of embryological development, none have been
revealed to be directly involved in uteric-bud/metanephric-
blastema interface disruption.3–5 This notion is supported
by a study on the kidneys of pre-term infants show-
ing an abundance of calcification-promoting molecules,
specifically osteopontin and hyaluronan, expressed at the
luminal side of the renal tubular differentiating cells.6
There was no mention made of the role of MSK in
my recent paper7 because the true advancement in this
field needs to be substantiated. This could be achieved by
direct tissue examination of the renal papillary structure
in affected patients for both the presence of undifferen-
tiated embryonal tissue and for the expression of various
potential genes participating in nephronal development.
The metabolic abnormalities that were mentioned by
Stratta et al.1 are only associations that may contribute
to kidney stone formation but are not causal in the
pathogenesis of this disease.8
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To the Editor: It is with interest that we read the report
of Sun et al.1 on how hypoxia-inducible factor-1a (HIF-1a)
induces TWIST1 expression in human tubule cell lines,
providing a model for hypoxia-induced renal fibrosis. Their
findings complement two earlier papers linking hypoxic
signaling to TWIST1 expression. In a functional screen in
Caenorhabditis elegans, TWIST1 was identified as a HIF
target, and in human cancer cells, hypoxia induces TWIST1
expression and epithelial–mesenchymal transition.2–4 Impor-
tantly, silencing of TWIST1 attenuates metastatic cancer
outgrowth in xenograft models.4 Taken together, these
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earlier studies had already established an important role for
hypoxia-induced TWIST1 expression.
Whereas both Yang et al. and Sun et al. observe a role for
HIF-1a in regulating TWIST1 through hypoxia-responsive
elements in the TWIST1 proximal promoter, we showed
a regulation of TWIST1 by HIF-2, the HIF-1 ortholog.
Importantly, HIF-2a induces TWIST1 expression using a
distinct intronic hypoxia-responsive element rather than
through the proximal TWIST1 promoter.3 Although we
excluded an involvement of HIF-1 in both intronic and
proximal hypoxia-responsive element regulation of TWIST1,
other studies have not addressed a role for HIF-2.
Therefore, it seems that hypoxic TWIST1 induction is
regulated by both HIF-1a and HIF-2a proteins through
distinct regulatory elements in a tissue-specific manner
(Figure 1). It is clear that the hypoxic regulation of TWIST1
plays a key role in hypoxic epithelial–mesenchymal transition
induction and metastases formation. It will be interesting
to learn the mechanistic and clinical importance of the
HIF-1- versus the HIF-2-mediated regulation of TWIST1 in
disease processes.
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We thank Vooijs et al. for their interest and comments
about our paper.1 Vooijs et al. had found that hypoxia
induces Twist1 expression in a hypoxia-inducible factor
(HIF)-2a-dependent manner and that intronic hypoxia
response elements of Twist1 are regulated by HIF-2a.2
In our study, direct transcriptional activation of Twist by
HIF-1a was found to promote epithelial-to-mesenchymal
transition (EMT) in tubular cells.3 Yang et al.4 also showed
that HIF-1a directly regulates the expression of Twist by
binding to hypoxia-responsive elements in the Twist
proximal promoter, resulting in EMT and metastastic
phenotypes. Thus, Twist may be the target gene of both
HIF-1a and HIF-2a. However, we think the role of Twist
in hypoxia-induced renal EMT and fibrosis is mediated
only by HIF-1a, not HIF-2a.
The expressions of both HIF-1a and HIF-2a are tissue-
and cell type–specific. HIF-1a is ubiquitously expressed,
whereas HIF-2a expression is more restricted. HIF-2a has
been found in hepatocytes, cardiomyocytes, glial cells, type
II pneumocytes, and endothelial cells. In addition, it has
been reported that HIF-1a and-2a are also expressed in
different renal cell populations.5 HIF-1a is mainly induced
in tubular cells as well as in proximal tubules, distal
tubules, and connecting tubes. Although HIF-2a is not
expressed in tubular cells, it is expressed in the endothelial
cells of a small subset of glomeruli and in peritubular
endothelial cells and fibroblasts. The selective induction of
HIF-1a and -2a in different types of cells in the kidney
should use different aspects of hypoxic response pathways
in a cell type–specific or temporospatial manner. It would
be interesting to further investigate the potential roles of
the HIF-2a in hypoxic kidney.
In conclusion, although hypoxic Twist induction is
regulated by both HIF-1a and HIF-2a in some specific cell
types, including cancer cells, we feel that Twist-induced
renal EMT and fibrosis under hypoxia are dominantly
mediated by an HIF-1a-dependent pathway.
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Figure 1 | Schematic representation of the TWIST1 genomic
structure and the putative hypoxia-responsive elements
(HREs) involved in TWIST1 regulation by hypoxia-inducible
factor (HIF) proteins. Exons (white boxes), the coding sequence
(gray box), and the HREs (black boxes) are shown here. Nucleotide
positions of functional HREs in the TWIST1 genomic locus bound
by HIF-1a or HIF-2a proteins in different systems are indicated
(see text for details). EMT, epithelial–mesenchymal transition.
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